Edition:
India

Lee's Pharmaceutical Holdings Ltd (0950.HK)

0950.HK on Hong Kong Stock

9.95HKD
17 Jul 2018
Change (% chg)

HK$-0.05 (-0.50%)
Prev Close
HK$10.00
Open
HK$10.00
Day's High
HK$10.00
Day's Low
HK$9.82
Volume
453,000
Avg. Vol
1,733,688
52-wk High
HK$14.70
52-wk Low
HK$6.01

Latest Key Developments (Source: Significant Developments)

Lee's Pharmaceutical Says Gets Approval For Conducting Clinical Trials For TG02 From China FDA
Thursday, 14 Jun 2018 

June 14 (Reuters) - Lee's Pharmaceutical Holdings Ltd <0950.HK>::CHINA FOOD AND DRUG ADMINISTRATION GRANTED APPROVAL FOR CONDUCTING CLINICAL TRIALS FOR TG02.  Full Article

Lee's Pharmaceutical Posts Q1 Profit Attributable Of HK$70.2 Mln
Thursday, 24 May 2018 

May 24 (Reuters) - Lee's Pharmaceutical Holdings Ltd <0950.HK>::Q1 PROFIT ATTRIBUTABLE HK$70.2 MILLION VERSUS HK$46.4 MILLION.QTRLY REVENUE HK$281.905 MILLION VERSUS HK$226.200 MILLION.  Full Article

Lee's Pharmaceutical Holdings says ‍qtrly profit attributable HK$61.8 mln
Thursday, 23 Nov 2017 

Nov 23 (Reuters) - Lee's Pharmaceutical Holdings Ltd <0950.HK>:‍Qtrly profit attributable to owners of company HK$61.8 million versus HK$72.8 million.Qtrly revenue HK$275.0 million versus HK$248.9 million a year ago.  Full Article

BRIEF-Lee's Pharmaceutical Holdings Says China FDA Grants Unit Approval For Clinical Trials

* CHINA FDA GRANTS UNIT APPROVAL FOR CLINICAL TRIALS FOR ITS RECOMBINANT HUMAN ANTI-PD-L1 MONOCLONAL ANTIBODY INJECTION Source text for Eikon: Further company coverage: